Showing results (1081-1090 of 1,193) with videos related to
Sort By:
Pageof 120
Veterinary World|February 3, 2025
Anti-adherent effects of <i>Rhizophora apiculata</i> bark and leaf extracts and computational prediction of the effects of its compound on β-tubulin interaction in <i>Acanthamoeba triangularis</i> genotype 4Siriphorn Chimplee, Imran Sama-Ae, Suthinee Sangkanu, et al.Journal of Pharmaceutical Sciences|April 28, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasetsPatrick Poulin, Hannah M Jones, Rhys Do Jones, et al.Journal of Pharmaceutical Sciences|April 12, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approachRagini Vuppugalla, Punit Marathe, Handan He, et al.Molecular Cell|March 17, 2018
The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma CellsRuiting Lin, Siyuan Xia, Changliang Shan, et al.Circulation Research|August 12, 2021
Dach1 Extends Artery Networks and Protects Against Cardiac InjuryBrian Raftrey, Ian Williams, Pamela E Rios Coronado, et al.Developmental Cell|August 9, 2017
The Helicase Aquarius/EMB-4 Is Required to Overcome Intronic Barriers to Allow Nuclear RNAi Pathways to Heritably Silence TranscriptionAlper Akay, Tomas Di Domenico, Kin M Suen, et al.DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|May 14, 2011
Defining the transcriptome assembly and its use for genome dynamics and transcriptome profiling studies in pigeonpea (Cajanus cajan L.)Anuja Dubey, Andrew Farmer, Jessica Schlueter, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2024
Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppressionPoonam Yadav, Kajal Rana, Viviani Nardini, et al.Nature Communications|March 19, 2022
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapyJianjie Li, Xiaodong Shu, Jun Xu, et al.Journal of Pharmaceutical Sciences|May 5, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearanceBarbara J Ring, Jenny Y Chien, Kimberly K Adkison, et al.Pageof 120